Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Politis

Showing results (131-140 of 141) with videos related to

Pageof 15
Sort By:
Human Biology|January 5, 2002
A worldwide analysis of AG molecular diversity inferred from serologyA Sanchez-Mazas, E Bütler-Brunner, R Bütler, et al.
Scientific Reports|April 21, 2021
Automatic 3D dense phenotyping provides reliable and accurate shape quantification of the human mandiblePieter-Jan Verhelst, H Matthews, L Verstraete, et al.
International Journal of Oral and Maxillofacial Surgery|June 2, 2021
Patient- and clinician-reported outcomes for the additively manufactured sub-periosteal jaw implant (AMSJI) in the maxilla: a prospective multicentre one-year follow-up studyC Van den Borre, M Rinaldi, B De Neef, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2014
West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmissionD Pervanidou, M Detsis, K Danis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- miceK Podsypanina, R T Lee, C Politis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitorsT van Cann, T Loyson, A Verbiest, et al.
Vox Sanguinis|November 30, 1999
Haemovigilance systemsC P Engelfriet, H W Reesink, B Brand, et al.
Vox Sanguinis|April 28, 2009
New cellular therapies: is there a role for transfusion services?H W Reesink, S Panzer, M Dettke, et al.
Vox Sanguinis|November 16, 2006
Prevention and diagnosis of delayed haemolytic transfusion reactionsC P Engelfriet, H W Reesink, R Fontão-Wendel, et al.
Vox Sanguinis|May 10, 2005
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003J Coste, H W Reesink, C P Engelfriet, et al.
Pageof 15

Showing results (131-140 of 141) with videos related to

Sort By:
Pageof 15
Human Biology|January 5, 2002
A worldwide analysis of AG molecular diversity inferred from serologyA Sanchez-Mazas, E Bütler-Brunner, R Bütler, et al.
Scientific Reports|April 21, 2021
Automatic 3D dense phenotyping provides reliable and accurate shape quantification of the human mandiblePieter-Jan Verhelst, H Matthews, L Verstraete, et al.
International Journal of Oral and Maxillofacial Surgery|June 2, 2021
Patient- and clinician-reported outcomes for the additively manufactured sub-periosteal jaw implant (AMSJI) in the maxilla: a prospective multicentre one-year follow-up studyC Van den Borre, M Rinaldi, B De Neef, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|April 12, 2014
West Nile virus outbreak in humans, Greece, 2012: third consecutive year of local transmissionD Pervanidou, M Detsis, K Danis, et al.
Proceedings of the National Academy of Sciences of the United States of America|August 16, 2001
An inhibitor of mTOR reduces neoplasia and normalizes p70/S6 kinase activity in Pten+/- miceK Podsypanina, R T Lee, C Politis, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|October 1, 2017
Incidence of medication-related osteonecrosis of the jaw in patients treated with both bone resorption inhibitors and vascular endothelial growth factor receptor tyrosine kinase inhibitorsT van Cann, T Loyson, A Verbiest, et al.
Vox Sanguinis|November 30, 1999
Haemovigilance systemsC P Engelfriet, H W Reesink, B Brand, et al.
Vox Sanguinis|April 28, 2009
New cellular therapies: is there a role for transfusion services?H W Reesink, S Panzer, M Dettke, et al.
Vox Sanguinis|November 16, 2006
Prevention and diagnosis of delayed haemolytic transfusion reactionsC P Engelfriet, H W Reesink, R Fontão-Wendel, et al.
Vox Sanguinis|May 10, 2005
Implementation of donor screening for infectious agents transmitted by blood by nucleic acid technology: update to 2003J Coste, H W Reesink, C P Engelfriet, et al.
Pageof 15